These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18374989)

  • 41. Interferon-inducible Ifi200-family genes as modifiers of lupus susceptibility.
    Choubey D
    Immunol Lett; 2012 Sep; 147(1-2):10-7. PubMed ID: 22841963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction.
    Brint EK; Fitzgerald KA; Smith P; Coyle AJ; Gutierrez-Ramos JC; Fallon PG; O'Neill LA
    J Biol Chem; 2002 Dec; 277(51):49205-11. PubMed ID: 12368275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of nuclear factor-kappa B and mitogen-activated protein kinase signaling pathways in IL-1 beta-mediated induction of alpha-PDGF receptor expression in rat pulmonary myofibroblasts.
    Lindroos PM; Rice AB; Wang YZ; Bonner JC
    J Immunol; 1998 Oct; 161(7):3464-8. PubMed ID: 9759865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sle1ab mediates the aberrant activation of STAT3 and Ras-ERK signaling pathways in B lymphocytes.
    Liu K; Liang C; Liang Z; Tus K; Wakeland EK
    J Immunol; 2005 Feb; 174(3):1630-7. PubMed ID: 15661926
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
    Leo V; Stefanachi A; Nacci C; Leonetti F; de Candia M; Carotti A; Altomare CD; Montagnani M; Cellamare S
    J Pharm Pharmacol; 2015 Oct; 67(10):1380-92. PubMed ID: 26078032
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-Jun amino-terminal kinase.
    Hossain K; Akhand AA; Kato M; Du J; Takeda K; Wu J; Takeuchi K; Liu W; Suzuki H; Nakashima I
    J Immunol; 2000 Oct; 165(8):4290-7. PubMed ID: 11035063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice.
    Wu L; Jiang X; Qi C; Zhang C; Qu B; Shen N
    Front Immunol; 2021; 12():653989. PubMed ID: 33868295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. delta opioid receptors stimulate Akt-dependent phosphorylation of c-jun in T cells.
    Shahabi NA; McAllen K; Sharp BM
    J Pharmacol Exp Ther; 2006 Feb; 316(2):933-9. PubMed ID: 16249373
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation.
    Guicheux J; Lemonnier J; Ghayor C; Suzuki A; Palmer G; Caverzasio J
    J Bone Miner Res; 2003 Nov; 18(11):2060-8. PubMed ID: 14606520
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hydrogen peroxide signaling through tumor necrosis factor receptor 1 leads to selective activation of c-Jun N-terminal kinase.
    Pantano C; Shrivastava P; McElhinney B; Janssen-Heininger Y
    J Biol Chem; 2003 Nov; 278(45):44091-6. PubMed ID: 12939259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Murine BAFF expression is up-regulated by estrogen and interferons: implications for sex bias in the development of autoimmunity.
    Panchanathan R; Choubey D
    Mol Immunol; 2013 Jan; 53(1-2):15-23. PubMed ID: 22784990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The candidate lupus susceptibility gene Ifi202a is largely dispensable for B-cell function.
    Gubbels Bupp MR; Li M; Pashine A; Aud D; Peng SL
    Rheumatology (Oxford); 2008 Jan; 47(1):103-4. PubMed ID: 18037609
    [No Abstract]   [Full Text] [Related]  

  • 53. Vav synergizes with protein kinase C theta to mediate IL-4 gene expression in response to CD28 costimulation in T cells.
    Hehner SP; Li-Weber M; Giaisi M; Dröge W; Krammer PH; Schmitz ML
    J Immunol; 2000 Apr; 164(7):3829-36. PubMed ID: 10725744
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Galectin-1-induced down-regulation of T lymphocyte activation protects (NZB x NZW) F1 mice from lupus-like disease.
    Liu SD; Lee S; La Cava A; Motran CC; Hahn BH; Miceli MC
    Lupus; 2011 Apr; 20(5):473-84. PubMed ID: 21335401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atypical signaling defects prevent IL-2 gene expression in lpr/lpr CD4-CD8- cells.
    Liang HE; Hsueh YP; Wu CC; Hsu SC; Han SH; Lai MZ
    J Biomed Sci; 1998; 5(4):297-304. PubMed ID: 9691223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distinct domains of mouse dishevelled are responsible for the c-Jun N-terminal kinase/stress-activated protein kinase activation and the axis formation in vertebrates.
    Moriguchi T; Kawachi K; Kamakura S; Masuyama N; Yamanaka H; Matsumoto K; Kikuchi A; Nishida E
    J Biol Chem; 1999 Oct; 274(43):30957-62. PubMed ID: 10521491
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD28 is not required for c-Jun N-terminal kinase activation in T cells.
    Rivas FV; O'Herrin S; Gajewski TF
    J Immunol; 2001 Sep; 167(6):3123-8. PubMed ID: 11544297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential activation of c-Jun NH2-terminal kinase and p38 pathways during FTY720-induced apoptosis of T lymphocytes that is suppressed by the extracellular signal-regulated kinase pathway.
    Matsuda S; Minowa A; Suzuki S; Koyasu S
    J Immunol; 1999 Mar; 162(6):3321-6. PubMed ID: 10092785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.
    Paik YH; Schwabe RF; Bataller R; Russo MP; Jobin C; Brenner DA
    Hepatology; 2003 May; 37(5):1043-55. PubMed ID: 12717385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Signaling by the JNK group of MAP kinases. c-jun N-terminal Kinase.
    Dong C; Davis RJ; Flavell RA
    J Clin Immunol; 2001 Jul; 21(4):253-7. PubMed ID: 11506194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.